Literature DB >> 16547358

Overview on visceral manifestations of mitochondrial disorders.

J Finsterer1.   

Abstract

Mitochondriopathies (MCPs) that reach adult age not only manifest in the central and peripheral nervous systems, eyes, ears, and dermis, but also in visceral organs, such as endocrine organs, heart, liver, guts, kidneys and blood. Visceral manifestations occur as part of a multisystem involvement or rarely as single organ affection. Endocrinological abnormalities are found in the MELAS, MERRF , KSS , MID and DID MOAD syndromes. Cardiac involvement occurs in the MELAS, MERRF , KSS , CPEO, LHO N, NARP, and Leigh syndromes. Gastrointestinal manifestations are common in the MERRF , MNGI E, DID MOAD, and Leigh syndromes. Mitochondrial syndromes with renal manifestations are the KSS , Pearson, DID MOAD, and Leigh syndromes. The haematopoetic system is affected in the KSS , MERRF , and Leigh syndromes. In addition, visceral manifestations are found in many nonsyndromic MCPs. Although there is no causal therapy for MCPs, adequate symptomatic therapy, particularly of visceral manifestations, markedly improves quality of life and prognosis of these still often neglected or overlooked disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547358

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  12 in total

Review 1.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

2.  Electrocardiography as an early cardiac screening test in children with mitochondrial disease.

Authors:  Ran Baik; Jung Hyun Chae; Young Mock Lee; Hoon Chul Kang; Joon Soo Lee; Heung Dong Kim
Journal:  Korean J Pediatr       Date:  2010-05-31

3.  Current and emerging treatment options in the management of Friedreich ataxia.

Authors:  Michelangelo Mancuso; Daniele Orsucci; Anna Choub; Gabriele Siciliano
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

4.  Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents.

Authors:  Joachim Kienhöfer; Dagmar Johanna Franziska Häussler; Florian Ruckelshausen; Elisabeth Muessig; Klaus Weber; David Pimentel; Volker Ullrich; Alexander Bürkle; Markus Michael Bachschmid
Journal:  FASEB J       Date:  2009-02-19       Impact factor: 5.191

5.  Small Circular DNAs in Human Pathology.

Authors:  Stephany Carolina Barreto; Madhuri Uppalapati; Amitabha Ray
Journal:  Malays J Med Sci       Date:  2014-05

6.  Mitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhood.

Authors:  Kristin E D'Aco; Megan Manno; Colleen Clarke; Jaya Ganesh; Kevin E C Meyers; Neal Sondheimer
Journal:  Pediatr Nephrol       Date:  2012-11-08       Impact factor: 3.714

Review 7.  Mitochondrial calcium homeostasis as potential target for mitochondrial medicine.

Authors:  Carlotta Giorgi; Chiara Agnoletto; Angela Bononi; Massimo Bonora; Elena De Marchi; Saverio Marchi; Sonia Missiroli; Simone Patergnani; Federica Poletti; Alessandro Rimessi; Jan M Suski; Mariusz R Wieckowski; Paolo Pinton
Journal:  Mitochondrion       Date:  2011-07-21       Impact factor: 4.160

Review 8.  Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction.

Authors:  Yuliya Mikhed; Andreas Daiber; Sebastian Steven
Journal:  Int J Mol Sci       Date:  2015-07-13       Impact factor: 5.923

Review 9.  Gastrointestinal manifestations of mitochondrial disorders: a systematic review.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Therap Adv Gastroenterol       Date:  2016-10-06       Impact factor: 4.409

10.  Ophthalmoplegia in Mitochondrial Disease.

Authors:  Sang Jun Lee; Ji Hoon Na; Jinu Han; Young Mock Lee
Journal:  Yonsei Med J       Date:  2018-12       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.